| 1 | [SID11111000] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 2 | [SID11111000] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 3 | [SID11111000] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 4 | [SID11110999] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 5 | [SID11110999] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 6 | [SID11110999] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 7 | [SID11111000] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 8 | [SID11111000] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 9 | [SID103252134] | Unspecified | IC50 | 500 | Inhibitory activity against Plasmodium falciparum [AID158688, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | IC50 | 500 [uM] | | BioAssay | Inhibitory activity against Plasmodium falciparum | | AID | 158688 | | BioAssay type | Literature | | Target | | | PubMed | 9357523 | | Data Table |  |
|
| 10 | [SID11111000] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 11 | [SID103252134] | Unspecified | | | Time of recovery of righting reflux (RRT) in seconds was measured after administration of 200 mg/kg perorally in mice for the promotional effect on recovery from coma [AID119185, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Time of recovery of righting reflux (RRT) in seconds was measured after administration of 200 mg/kg perorally in mice for the promotional effect on recovery from coma | | AID | 119185 | | BioAssay type | Literature | | Target | | | PubMed | 1676756 | | Data Table |  |
|
| 12 | [SID103252134] | Unspecified | | | Time of recovery of spontaneous movement (SMT) in seconds was measured after administration of 200 mg/kg perorally in mice for the promotional effect on recovery from coma [AID119402, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Time of recovery of spontaneous movement (SMT) in seconds was measured after administration of 200 mg/kg perorally in mice for the promotional effect on recovery from coma | | AID | 119402 | | BioAssay type | Literature | | Target | | | PubMed | 1676756 | | Data Table |  |
|
| 13 | [SID103252134] | Unspecified | | | Antihypoxic effect tested by the survival time (SVT) in mice at a dose of 100 mg/kg [AID119554, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Antihypoxic effect tested by the survival time (SVT) in mice at a dose of 100 mg/kg | | AID | 119554 | | BioAssay type | Literature | | Target | | | PubMed | 1676756 | | Data Table |  |
|
| 14 | [SID103252134] | Unspecified | | | Antihypoxic effect by the survival time (SVT) in mice at a dose of 3 mg/kg administered intravenously in mice [AID119565, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Antihypoxic effect by the survival time (SVT) in mice at a dose of 3 mg/kg administered intravenously in mice | | AID | 119565 | | BioAssay type | Literature | | Target | | | PubMed | 1676756 | | Data Table |  |
|
| 15 | [SID103252134] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 16 | [SID103252134] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 17 | [SID103252134] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103252134 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 18 | [SID11111000] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 19 | [SID11111000] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 20 | [SID11110999] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 21 | [SID11110999] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 22 | [SID11111000] | Inactive | Potency | 0.2818 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 0.2818 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 23 | [SID11111000] | Inactive | Potency | 0.2818 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 0.2818 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 24 | [SID11111000] | Inactive | Potency | 0.5725 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 0.5725 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID11111000] | Inactive | Potency | 0.9762 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 0.9762 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 26 | [SID11110999] | Inactive | Potency | 1.2589 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 27 | [SID11110999] | Inactive | Potency | 1.2589 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 28 | [SID11110999] | Inactive | Potency | 1.2589 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 29 | [SID11111000] | Inactive | Potency | 2.5575 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 2.5575 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID11111000] | Inactive | Potency | 10 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 31 | [SID11111000] | Inactive | Potency | 10 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 32 | [SID90341454] | Inactive | Potency | 25.1189 | qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation [AID624146, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 90341454 | | CID | 4039 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation | | AID | 624146 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 33 | [SID90341454] | Inactive | Potency | 42.5615 | qHTS Validation Assay to Find Inhibitors of Pin1 [AID504536, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 90341454 | | CID | 4039 | | Outcome | Inactive | | Potency | 42.5615 [uM] | | BioAssay | qHTS Validation Assay to Find Inhibitors of Pin1 | | AID | 504536 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 34 | [SID90341454] | Inactive | Potency | 42.5615 | qHTS Validation Assay to Find Inhibitors of Pin1 [AID504536, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 90341454 | | CID | 4039 | | Outcome | Inactive | | Potency | 42.5615 [uM] | | BioAssay | qHTS Validation Assay to Find Inhibitors of Pin1 | | AID | 504536 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 35 | [SID11110999] | Inactive | Potency | | qHTS Assay for Activators of Human Muscle Pyruvate Kinase [AID954, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human Muscle Pyruvate Kinase | | AID | 954 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 36 | [SID11110999] | Inactive | Potency | | qHTS Assay for Activators of Human Muscle Pyruvate Kinase [AID954, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human Muscle Pyruvate Kinase | | AID | 954 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 37 | [SID11110999] | Inactive | Potency | | qHTS Assay for Activators of Human Muscle Pyruvate Kinase [AID954, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human Muscle Pyruvate Kinase | | AID | 954 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 38 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase [AID958, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase | | AID | 958 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 39 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase [AID958, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase | | AID | 958 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 40 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase [AID958, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286420] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase | | AID | 958 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286420] | | PubMed | | | Data Table |  |
|
| 41 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 42 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 43 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 44 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 45 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 46 | [SID11111000] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 11111000 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 47 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 48 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 49 | [SID11110999] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 11110999 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 50 | [SID90341454] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 90341454 | | CID | 4039 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|